Protagonist Therapeutics Inc (PTGX) with a beta value of 2.20 appears to be a promising investment opportunity.
On Tuesday, Protagonist Therapeutics Inc (NASDAQ: PTGX) was -4.31% drop from the session before settling in for the closing price of $40.39. A 52-week range